Gem Aromatics Ltd (GEMAROMA) — shareholding pattern, promoter holding, financials and share price
About Gem Aromatics Ltd (GEMAROMA)
Gem Aromatics Ltd operates in the Specialty Chemicals industry, within the Chemicals sector. It trades on the NSE as GEMAROMA and on the BSE under scrip code 544491. Its ISIN is INE06XZ01023.
Incorporated in October 1997, Gem Aromatics Limited manufactures speciality ingredients, including essential oils, aroma chemicals, and Value-Added Derivatives in India. [1]
Gem Aromatics Limited is a prominent Indian manufacturer of essential oils, aroma chemicals, and value-added derivatives. The company has expanded to serve various industries including personal care, pharmaceuticals, and wellness.
The commissioning of the Dahej plant in December 2025 marked a pivotal expansion, enhancing capacity by threefold alongside introducing new product lines like cooling agents.
Listed peers in Specialty Chemicals: Jyoti Resins and Adhesives Ltd, Oriental Aromatics Ltd, Excel Industries Ltd, Sunshield Chemicals Ltd, Sudarshan Pharma Industries Ltd, Shri Ahimsa Naturals Ltd.
Valuation & Returns
10 Jul 2026At ₹205.9 a share on 10 Jul 2026, Gem Aromatics Ltd (GEMAROMA) was valued at a price-to-earnings ratio of 757.44x against an industry P/E of 45.11x and a price-to-book of 3.79x on a book value of ₹54.36 per share as of Mar 2025. Solomo computes return on equity of 0.5% and return on capital employed of 3.72% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 757.44x
- Industry P/E
- 45.11x
- P/B
- 3.79x
- EPS (TTM)
- ₹0.27
- Book value / share
- ₹54.36
- ROE
- 0.5%
- ROCE
- 3.72%
- ROA
- 0.27%
- Debt / equity
- 0.79x
- Dividend yield
- 0%
- EBITDA margin
- 11.33%
- 52-week range
- ₹133.1 – ₹349
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Gem Aromatics Ltd (GEMAROMA) reported revenue of ₹366 crore, net profit of ₹1 crore and earnings per share of ₹0.27. That compares with revenue of ₹504 crore and net profit of ₹53 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹110.41 crore and net profit ₹1.01 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 314 | 425 | 452 | 504 | 366 |
| Net profit (₹ cr) | 31 | 45 | 50 | 53 | 1 |
| EPS (₹) | 174.74 | 250.27 | 10.69 | 11.39 | 0.27 |
| Measure | 3Y | 1Y |
|---|---|---|
| Sales growth | 18.04% | 11.38% |
| Profit growth | 22.39% | 6.55% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 57.45% of Gem Aromatics Ltd (GEMAROMA) (up 0.44 pp QoQ), foreign institutional investors (FII) hold 0.75% and domestic institutional investors (DII) hold 4.81%. Market capitalisation was ₹1,076 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2025.
Largest disclosed public shareholders in Jun 2026: DOTERRA ENTERPRISES S.A.R.L. 18.36%, NIPPON INDIA EQUITY OPPORTUNITIES AIF - SCHEME 7 1.8%, SAGEONE-FLAGSHIP GROWTH OE FUND 1.59%, HUF 1.2%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 57.45% | - | 0.75% | 4.81% | 42.55% |
| Mar 2026 | 57.01% | - | 1.06% | 4.81% | 42.99% |
| Dec 2025 | 55.06% | - | 0.79% | 4.59% | 44.94% |
| Sep 2025 | 55.06% | - | 2.01% | 6.56% | 44.94% |